Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Obesity with hepatic steatosis : Patients with BMI 30 kg/m (or 27 kg/m with weight-related comorbidities) and documented fatty liver may benefit from GLP-1 agonists approved for chronic weight management
The dual-agonist approach appears to produce greater glycemic control and weight reduction compared to selective GLP-1 receptor agonists in clinical trials
Vit-D can modulate both innate and adaptive immune responses, and vit-D deficiency is linked to increased autoimmunity as well as increased susceptibility to microbial infections
If you experienced diarrhea or fluid loss during prep, electrolyte-balanced beverages can help restore balance before your next dose
US$ 26.99
US$ 27.21
US$ 22.02
US$ 20.18
